Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c00748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Yusuke Tanaka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hiro-koshingai, Kure, Hiroshima 737-0112, …. Hauptthemen laut MEDLINE: Ribavirin, Intestines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hiro-koshingai, Kure, Hiroshima 737-0112, Japan.
ORCID-Profile: Yusuke Tanaka
Zitieren
APA
Tanaka, Y., Ito, K., Kurakazu, T., & Kasaoka, S. (2023). Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c00748
Vancouver
Tanaka Y, Ito K, Kurakazu T, Kasaoka S. Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c00748
BibTeX
@article{Tanaka2023,
author = {Tanaka, Yusuke and Ito, Kazuhiro and Kurakazu, Takanori and Kasaoka, Satoshi},
title = {Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c00748}
}
EUVIMED